GPI attending the World EPA Congress

GPI will be attending the World EPA congress, held in Amsterdam RAI, on 12-13 March 2024. We will be located on stand 28, and our representatives will be on hand to discuss how GPI can optimise your pricing and market access decision-making in 2024 and beyond.

In addition we will be contributing to the conference program, discussing our innovative research on orphan drugs – utilising the only value assessment and price prediction platform on the market. Details below!

World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams and over 1200 attendees from pharma, biotech and Payers/HTA’s.

Come and visit our stand (28) to learn more about our value assessment and price prediction platform! We will be providing demonstrations and discussing the platform, in addition to showcasing how the horizon methodology can minimise the risk of your drug launch, reduce time-intensive payer research and maximise commercial success.

In addition, find out how we utilise data from GPI pulse™ for value, price, and market access insights – with a live demo. Our team will be at the conference to discuss and demonstrate how GPI pulse™ can help create more efficient, evidence-led market access strategies.

You will also be able to discuss pricing and market access challenges, stakeholder relationships discover innovative tools and solutions for the ecosystem. Most notably, GPI’s innovative suite of technological and service-based solutions, GPI pulse™ data analytics platform, and our unique platform solution, based on our award-winning methodology that quantifies an asset’s position in the market.

White Minimalist Simple Modern Business Webinar LinkedIn (1)

Share the Article:

Sign up to our mailing list to be informed of the latest webinars